236 related articles for article (PubMed ID: 20396635)
1. Impact of dronedarone in atrial fibrillation and flutter on stroke reduction.
Christiansen CB; Torp-Pedersen C; Køber L
Clin Interv Aging; 2010 Apr; 5():63-9. PubMed ID: 20396635
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of dronedarone: a review of randomized trials.
Christiansen CB; Torp-Pedersen C; Køber L
Expert Opin Drug Saf; 2010 Jan; 9(1):189-99. PubMed ID: 20001756
[TBL] [Abstract][Full Text] [Related]
3. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
Page RL; Connolly SJ; Crijns HJ; van Eickels M; Gaudin C; Torp-Pedersen C; Hohnloser SH;
Am J Cardiol; 2011 Apr; 107(7):1019-22. PubMed ID: 21296333
[TBL] [Abstract][Full Text] [Related]
4. Dronedarone: a promising alternative for the management of atrial fibrillation.
Yalta K; Turgut OO; Yilmaz MB; Yilmaz A; Tandogan I
Cardiovasc Drugs Ther; 2009 Oct; 23(5):385-93. PubMed ID: 19669399
[TBL] [Abstract][Full Text] [Related]
5. Impact of dronedarone on patients with atrial fibrillation and diabetes: A sub-analysis of the ATHENA and EURIDIS/ADONIS studies.
Handelsman Y; Bunch TJ; Rodbard HW; Steinberg BA; Thind M; Bigot G; Konigsberg L; Wieloch M; Kowey PR
J Diabetes Complications; 2022 Jul; 36(7):108227. PubMed ID: 35717354
[TBL] [Abstract][Full Text] [Related]
6. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.
Connolly SJ; Crijns HJ; Torp-Pedersen C; van Eickels M; Gaudin C; Page RL; Hohnloser SH;
Circulation; 2009 Sep; 120(13):1174-80. PubMed ID: 19752319
[TBL] [Abstract][Full Text] [Related]
7. Dronedarone therapy in atrial fibrillation: a summary of recent controlled trials.
Duray GZ; Schmitt J; Hohnloser SH
J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):19S-23S. PubMed ID: 20472812
[TBL] [Abstract][Full Text] [Related]
8. Dronedarone: an emerging agent with rhythm- and rate-controlling effects.
Wegener FT; Ehrlich JR; Hohnloser SH
J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S17-20. PubMed ID: 16939434
[TBL] [Abstract][Full Text] [Related]
9. Drug safety evaluation of dronedarone in atrial fibrillation.
De Ferrari GM; Dusi V
Expert Opin Drug Saf; 2012 Nov; 11(6):1023-45. PubMed ID: 22971242
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and pharmacodynamic profile of dronedarone , a new antiarrhythmic agent for the treatment of atrial fibrillation.
Rosa GM; Bianco D; Parodi A; Valbusa A; Zawaideh C; Bizzarri N; Ferrero S; Brunelli C
Expert Opin Drug Metab Toxicol; 2014 Dec; 10(12):1751-64. PubMed ID: 25349898
[TBL] [Abstract][Full Text] [Related]
11. A review of the appropriate and inappropriate use of dronedarone: lessons learned from controlled studies and regulatory submission.
Naccarelli GV; Wolbrette DL; Samii S; Banchs JE; Penny-Peterson E; Gonzalez MD
J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):24S-30S. PubMed ID: 21098416
[TBL] [Abstract][Full Text] [Related]
12. Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation.
Schweizer PA; Becker R; Katus HA; Thomas D
Drug Des Devel Ther; 2011 Jan; 5():27-39. PubMed ID: 21267357
[TBL] [Abstract][Full Text] [Related]
13. [Clinical profile of the new antiarrhythmic drug dronedarone].
Schmitt J; Lewalter T; Pittrow D; Duray G; Goette A; Brachmann J; Hohnloser SH
Dtsch Med Wochenschr; 2010 Mar; 135 Suppl 2():S38-42. PubMed ID: 20221977
[TBL] [Abstract][Full Text] [Related]
14. Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy.
Wolbrette D; Gonzalez M; Samii S; Banchs J; Penny-Peterson E; Naccarelli G
Vasc Health Risk Manag; 2010 Aug; 6():517-23. PubMed ID: 20730068
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of dronedarone in patients previously treated with other antiarrhythmic agents.
Guerra F; Hohnloser SH; Kowey PR; Crijns HJ; Aliot EM; Radzik D; Roy D; Connolly S; Capucci A
Clin Cardiol; 2014 Dec; 37(12):717-24. PubMed ID: 25470298
[TBL] [Abstract][Full Text] [Related]
16. Dronedarone: current evidence and future questions.
Schafer JA; Kjesbo NK; Gleason PP
Cardiovasc Ther; 2010; 28(1):38-47. PubMed ID: 20074258
[TBL] [Abstract][Full Text] [Related]
17. Dronedarone: drondarone, SR 33589, SR 33589B.
Drugs R D; 2007; 8(3):171-5. PubMed ID: 17472412
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of dronedarone versus placebo in patients with atrial fibrillation stratified according to renal function: Post hoc analyses of the EURIDIS-ADONIS trials.
Thind M; Zareba W; Atar D; Crijns HJGM; Zhu J; Pak HN; Reiffel J; Ludwigs U; Wieloch M; Stewart J; Kowey P
Clin Cardiol; 2022 Jan; 45(1):101-109. PubMed ID: 35019175
[TBL] [Abstract][Full Text] [Related]
19. Cost burden of cardiovascular hospitalization and mortality in ATHENA-like patients with atrial fibrillation/atrial flutter in the United States.
Naccarelli GV; Johnston SS; Lin J; Patel PP; Schulman KL
Clin Cardiol; 2010 May; 33(5):270-9. PubMed ID: 20513065
[TBL] [Abstract][Full Text] [Related]
20. Dronedarone.
Hoy SM; Keam SJ
Drugs; 2009 Aug; 69(12):1647-63. PubMed ID: 19678715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
